It has also been shown that overexpression of an oncogenic form of HER2 leads to strong expression of LIPG31 and LIPG has been reported to be associated with tumor growth 15 and with metastasis in triple-negative breast cancer 32. Here, ERBB2 is linked to triple-negative breast carcinoma.